2007
DeltaBio was founded as a spinoff company of the Hungarian Academy of Sciences to bridge the gap between academic research and the practical applications of molecular biology.
Delta Bio 2000
DeltaBio’s mission is to create a bridge between the frontiers of academic achievements and the practical applications of molecular biology. To help overcome the global challenges of our present times, we’re constantly on the lookout for new innovative partnership & collaboration opportunities around the world.
As a pioneering biotech company specializing in genomics & molecular diagnostics, we harness the power of novel technologies – such as next-generation sequencing (NGS) – to create custom solutions for our partners across a wide range of industries and applications.
Our expertise, state-of-the-art facilities, and unrivaled scientific acumen enable us to provide support throughout entire R&D processes, from meticulous planning to seamless execution and evaluation.
As an ISO9001 accredited company operating under the stringent ISO13485 quality management system, our partners can rest assured their projects will always adhere to the highest quality standards.
So, imagine your project requires basic molecular techniques (such as PCR or qPCR), or high-throughput, high-precision- or single-cell sequencing technologies, or even non-invasive diagnostics (like liquid biopsy or cell-free DNA isolation)...
– Our modern laboratories & instruments create the perfect environment to bring a wide range of research projects to life.
Our greatest assets, however, are our people. Their diverse laboratory experiences, up-to-date knowledge of the latest scientific advancements, and unquenchable curiosity ensure we’re here to help you handle any task, project, or challenge within the realms of molecular biology.
Our story
2015
Our first spinoff, DeltaGene, hits the market with our new NGS-based diagnostic services. This enables us to shift our focus to developing and nurturing R&D partnerships around the world.
2019
Our long-term international collaboration with DCGen opens new horizons, and enables us to make an impact in the South Korean healthcare market.
2022
We shift our center of operations to our new headquarters, Lab58. With over 1,000 m2 of state-of-the-art laboratory area, we scale our capacities to previously unimaginable levels.
2008
We develop our first molecular diagnostic CE-IVD certified products to help clinicians make personalized therapeutic decisions.
2017
We invest over €400,000 to upgrade our equipment fleet with cutting-edge Illumina instruments, ensuring we are continuously up-to-date with the latest industry standards.
2021
We expand our diagnostic services with liquid biopsy and introduce the highest ISO quality management systems to our operations.
2023
Our microbiome-diagnostics division, DeltaBiom, celebrates sequencing its 5,000th microbiome patient-sample.
Get in touch to unlock the immense potential of biotechnology and tie the latest scientific research to your practical applications. Only together can we redefine the boundaries of fields like healthcare, agriculture, or drug development.
Get in touch